p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa

Activation of apoptosis through transcriptional induction of Puma and Noxa has long been considered to constitute the critical (if not sole) process by which p53 suppresses tumor development, although G1/S boundary cell-cycle arrest via induction of the CDK inhibitor p21 has also been thought to co...

Full description

Bibliographic Details
Main Authors: Liz J. Valente, Daniel H.D. Gray, Ewa M. Michalak, Josefina Pinon-Hofbauer, Alex Egle, Clare L. Scott, Ana Janic, Andreas Strasser
Format: Article
Language:English
Published: Elsevier 2013-05-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124713001794
id doaj-c8b0052170ea409c904148d77c52dc70
record_format Article
spelling doaj-c8b0052170ea409c904148d77c52dc702020-11-25T02:29:00ZengElsevierCell Reports2211-12472013-05-01351339134510.1016/j.celrep.2013.04.012p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and NoxaLiz J. Valente0Daniel H.D. Gray1Ewa M. Michalak2Josefina Pinon-Hofbauer3Alex Egle4Clare L. Scott5Ana Janic6Andreas Strasser7The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, AustraliaLaboratory for Immunological and Molecular Cancer Research (LIMCR), Third Medical University Department for Hematology and Medical Oncology, Paracelsus Private Medical University Salzburg, Salzburg 5020, AustriaLaboratory for Immunological and Molecular Cancer Research (LIMCR), Third Medical University Department for Hematology and Medical Oncology, Paracelsus Private Medical University Salzburg, Salzburg 5020, AustriaThe Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia Activation of apoptosis through transcriptional induction of Puma and Noxa has long been considered to constitute the critical (if not sole) process by which p53 suppresses tumor development, although G1/S boundary cell-cycle arrest via induction of the CDK inhibitor p21 has also been thought to contribute. Recent analyses of mice bearing mutations that impair p53-mediated induction of select target genes have indicated that activation of apoptosis and G1/S cell-cycle arrest may, in fact, be dispensable for p53-mediated tumor suppression. However, the expression of Puma, Noxa, and p21 was not abrogated in these mutants, only reduced; therefore, the possibility that the reduced levels of these critical effectors of p53-mediated apoptosis and G1/S-cell-cycle arrest sufficed to prevent tumorigenesis could not be excluded. To resolve this important issue, we have generated mice deficient for p21, Puma, and Noxa (p21−/−puma−/−noxa−/− mice). Cells from these mice were deficient in their ability to undergo p53-mediated apoptosis, G1/S cell-cycle arrest, and senescence. Nonetheless, these animals remained tumor free until at least 500 days, in contrast to p53-deficient mice, which had all succumbed to lymphoma or sarcoma by 250 days. Interestingly, DNA lesions induced by γ-irradiation persisted longer in p53-deficient cells compared to wild-type or p21−/−puma−/−noxa−/− cells, and the former failed to transcriptionally activate several p53 target genes implicated in DNA repair. These results demonstrate beyond a doubt that the induction of apoptosis, cell-cycle arrest, and possibly senescence is dispensable for p53-mediated suppression of spontaneous tumor development and indicate that coordination of genomic stability and possibly other processes, such as metabolic adaptation, may instead be critical. http://www.sciencedirect.com/science/article/pii/S2211124713001794
collection DOAJ
language English
format Article
sources DOAJ
author Liz J. Valente
Daniel H.D. Gray
Ewa M. Michalak
Josefina Pinon-Hofbauer
Alex Egle
Clare L. Scott
Ana Janic
Andreas Strasser
spellingShingle Liz J. Valente
Daniel H.D. Gray
Ewa M. Michalak
Josefina Pinon-Hofbauer
Alex Egle
Clare L. Scott
Ana Janic
Andreas Strasser
p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
Cell Reports
author_facet Liz J. Valente
Daniel H.D. Gray
Ewa M. Michalak
Josefina Pinon-Hofbauer
Alex Egle
Clare L. Scott
Ana Janic
Andreas Strasser
author_sort Liz J. Valente
title p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
title_short p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
title_full p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
title_fullStr p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
title_full_unstemmed p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
title_sort p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, puma, and noxa
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2013-05-01
description Activation of apoptosis through transcriptional induction of Puma and Noxa has long been considered to constitute the critical (if not sole) process by which p53 suppresses tumor development, although G1/S boundary cell-cycle arrest via induction of the CDK inhibitor p21 has also been thought to contribute. Recent analyses of mice bearing mutations that impair p53-mediated induction of select target genes have indicated that activation of apoptosis and G1/S cell-cycle arrest may, in fact, be dispensable for p53-mediated tumor suppression. However, the expression of Puma, Noxa, and p21 was not abrogated in these mutants, only reduced; therefore, the possibility that the reduced levels of these critical effectors of p53-mediated apoptosis and G1/S-cell-cycle arrest sufficed to prevent tumorigenesis could not be excluded. To resolve this important issue, we have generated mice deficient for p21, Puma, and Noxa (p21−/−puma−/−noxa−/− mice). Cells from these mice were deficient in their ability to undergo p53-mediated apoptosis, G1/S cell-cycle arrest, and senescence. Nonetheless, these animals remained tumor free until at least 500 days, in contrast to p53-deficient mice, which had all succumbed to lymphoma or sarcoma by 250 days. Interestingly, DNA lesions induced by γ-irradiation persisted longer in p53-deficient cells compared to wild-type or p21−/−puma−/−noxa−/− cells, and the former failed to transcriptionally activate several p53 target genes implicated in DNA repair. These results demonstrate beyond a doubt that the induction of apoptosis, cell-cycle arrest, and possibly senescence is dispensable for p53-mediated suppression of spontaneous tumor development and indicate that coordination of genomic stability and possibly other processes, such as metabolic adaptation, may instead be critical.
url http://www.sciencedirect.com/science/article/pii/S2211124713001794
work_keys_str_mv AT lizjvalente p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT danielhdgray p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT ewammichalak p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT josefinapinonhofbauer p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT alexegle p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT clarelscott p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT anajanic p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
AT andreasstrasser p53efficientlysuppressestumordevelopmentinthecompleteabsenceofitscellcycleinhibitoryandproapoptoticeffectorsp21pumaandnoxa
_version_ 1724834978642001920